A Quality Improvement Project to Investigate Individual Provider Variation in Opioid Prescribing From the Emergency Department
調査の概要
状態
詳細な説明
Opioid misuse is a known public safety threat and public health problem, both nationwide and in the Commonwealth of Massachusetts. As a part of these efforts, Emergency Department (ED) outpatient prescriptions have been identified as a potential area for improvement. The Massachusetts Hospital Association (MHA), in conjunction with other stakeholders, developed a set of recommendations to address opioid management and prescribing within the ED setting.
This study is timed to coincide with the rollout by UMassMemorial Health Care of a system-wide opioid prescribing practice guideline/policy which mirrors the Massachusetts Hospital Association's guideline. This rollout provides a unique opportunity for a natural experiment related to provider prescribing practices.
This is a quality improvement project with two primary objectives:
- Improve understanding of physician practice patterns related to emergency department (ED) opioid prescribing
- Evaluate the effectiveness of providing individual clinician profile data in influencing behavior change among ED providers, as it relates to their opioid prescribing patterns
There are two corresponding specific aims:
- Quantitatively describe the current state of opioid prescribing by ED clinicians at four UMass Memorial EDs (using prescriptions generated within the ED electronic health information system between February 2014 and the study implementation date). Descriptive statistics being considered for feasibility of study include:
- Number of opioid prescriptions per hundred patients seen
- Percentage of total prescriptions written that are opioids
- Mean or median quantity of pills dispensed per opioid prescription
- Number of prescriptions for long-acting opioid formulations
- Evaluate the effect on prescribing practices of providing individual clinicians with their profile data to illustrate their personal opioid prescribing patterns, relative to the de-identified distribution for all other clinicians in the ED group
This project is timed to coincide with the separately planned implementation of a system-wide opioid prescribing guideline. The guideline implementation is an independent event, but we feel that it presents a unique opportunity for a simultaneous experimental intervention to assess whether providing clinicians with their individual data alters their prescribing practices beyond any effect achieved simply by being subject to the new guideline. Data collected from the electronic medical record and clinician self-reported data about their perceptions of their prescribing practices will be used to evaluate both the effect of the guideline implementation (i.e. comparison of prescribing patterns for all clinicians before and after guideline implementation) and the combined effect of guideline implementation plus individual profile intervention (i.e. comparisons across intervention versus control groups).
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
Massachusetts
-
Clinton、Massachusetts、アメリカ
- UMass Clinton Hospital
-
Marlborough、Massachusetts、アメリカ
- UMass Memorial Marlborough Hospital
-
Worcester、Massachusetts、アメリカ
- UMass Memorial Medical Center
-
-
参加基準
適格基準
就学可能な年齢
- 子
- 大人
- 高齢者
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Provider who practices Emergency Medicine in one or more of four UMass-affiliated EDs (UMassMemorial Medical Center, Marlborough Hospital, and Clinton Hospital), including attending physicians, resident physicians, and advanced practice providers (PAs and NPs).
- Have placed at least one electronic prescription for a medication of interest (namely opioids) in the PulseCheck electronic medical record system during the 12 months prior to the implementation of the opioid guidelines
- Be actively practicing in a UMass-affiliated ED at time of implementation of the guidelines
Exclusion Criteria:
- None
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:ヘルスサービス研究
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
介入なし:Control
Providers who are subject only to the routine implementation of clinical practice guidelines without additional experimental intervention
|
|
|
実験的:Intervention
Providers who are subject to routine clinical practice guideline implementation AND receive provider's own individual prescribing data profile intervention ("Individual prescribing data profile and self-assessment")
|
Prior to receiving his or her individual data profile, each provider in the intervention group will be asked to identify his or her self-assessment of his or her own opioid prescribing practices.
Immediately after providing self-perception data, providers will be provided with their true profile data with a visual display of where they fall within the distribution of their peers.
All peer data are de-identified.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
時間枠 |
|---|---|
|
Change in number of opioid prescriptions per hundred patients seen
時間枠:Pre-intervention baseline compared to 1, 2, 3, 6, 9, 12 months post-intervention
|
Pre-intervention baseline compared to 1, 2, 3, 6, 9, 12 months post-intervention
|
二次結果の測定
結果測定 |
時間枠 |
|---|---|
|
Change in percentage of total prescriptions written that are opioids
時間枠:Pre-intervention baseline compared to 1, 2, 3, 6, 9, 12 months post-intervention
|
Pre-intervention baseline compared to 1, 2, 3, 6, 9, 12 months post-intervention
|
|
Change in median quantity of pills dispensed per opioid prescription
時間枠:Pre-intervention baseline compared to 1, 2, 3, 6, 9, 12 months post-intervention
|
Pre-intervention baseline compared to 1, 2, 3, 6, 9, 12 months post-intervention
|
|
Change in number of prescriptions for long-acting opioid formulations
時間枠:Pre-intervention baseline compared to 1, 2, 3, 6, 9, 12 months post-intervention
|
Pre-intervention baseline compared to 1, 2, 3, 6, 9, 12 months post-intervention
|
その他の成果指標
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Self-assessment of decile for number of opioid prescriptions per hundred patients seen
時間枠:Once, at time of enrollment
|
The provider's self-assessment of their decile of number of opioid prescriptions per hundred patients seen, compared to their peers
|
Once, at time of enrollment
|
|
Self-assessment of decile for percentage of total prescriptions written that are opioids
時間枠:Once, at time of enrollment
|
The provider's self-assessment of their decile of their percentage of total prescriptions written that are opioids, compared to their peers
|
Once, at time of enrollment
|
|
Self-assessment of decile for median quantity of pills dispensed per opioid prescription
時間枠:Once, at time of enrollment
|
The provider's self-assessment of their decile of their median quantity of pills dispensed per opioid prescription, compared to their peers
|
Once, at time of enrollment
|
|
Self-assessment of decile for number of prescriptions for long-acting opioid formulations
時間枠:Once, at time of enrollment
|
The provider's self-assessment of their decile of their number of prescriptions for long-acting opioid formulations, compared to their peers
|
Once, at time of enrollment
|
協力者と研究者
捜査官
- 主任研究者:Sean Michael, MD、UMass Memorial Health Care
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。